Somatostatin Receptor Imaging with [18F]FET-ßAG-TOCA PET/CT and [68Ga]Ga-DOTA-Peptide PET/CT in Patients with Neuroendocrine Tumors: A Prospective, Phase 2 Comparative Study. (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2967/jnumed.123.266601
PubMed Identifier: 38331457
Publication URI: http://europepmc.org/abstract/MED/38331457
Type: Journal Article/Review
Parent Publication: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 0161-5505